GO
Loading...
 
 Highlight transcript below to create clip
Transcript:  Print  |  Email
    This term does not appear
Go
 Click text to jump within video

NPS Pharma CEO: Natpara will have greater potential than Gattex

Thu 10 Oct 13 | 02:23 PM ET
Francois Nader, NPS Pharmaceuticals president & CEO, discusses its lead product Gattex for "short bowel syndrome," the potential for Natpara and the solid performance of its stock.

Topics:

Economy (U.S.) Biotechnology

Sectors:

 | Drug Retail
 
RELATED ARTICLES AND CONTENT
More Videos
  • No Articles Available
Latest Videos
Why this expert still prefers DMs over EMs
Mon 21 Apr 14 | 12:02 AM ET
Latest Videos
UBS: See 8% growth for US earnings this year
Sun 20 Apr 14 | 11:08 PM ET
Latest Videos
See dollar-yen at 110 in long-term: Macquarie
Sun 20 Apr 14 | 10:47 PM ET
Latest Videos
China-made vehicles have high quality: IHS
Sun 20 Apr 14 | 10:39 PM ET
Go
Displaying results for: Latest Video | US